MedTrace Logo

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

NCT07542327 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-04-24

No results posted yet for this study

Summary

The purpose of this study is to explore if GPCR-autoantibodies:

1. are pressent in people living with obesity, and are associated with degree of obesity
2. if it is associated with obesity related diseases

Conditions

  • Obesity
  • Obesity & Overweight
  • Obesity Type 2 Diabetes Mellitus
  • Obesity and Obesity-related Medical Conditions

Sponsors & Collaborators

  • Claus Bogh Juhl

    lead OTHER

Principal Investigators

  • Claus B Juhl, Professor, MD, PhD · University Hospital of Southern Denmark, Esbjerg

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-09-01
Completion
2027-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07542327 on ClinicalTrials.gov